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Introduction

Biomimetic Display of Influenza Nucleoprotein

Virus like particles (VLPs) present a rich biomaterial architecture and platform for
displaying antigens in a spatially controlled manner, either on the exterior and/or on the
interior, which could be exploited to direct specific immune response pathways. The VLP
derived from Salmonella typhimurium bacteriophage P22 has been shown to be a versatile
platform for the incorporation of proteins on the VLP interior. Heterologous co-expression of
a protein or peptide cargo of choice fused to the P22 scaffolding protein (SP) with P22 coat
protein leads to assembly of the P22 VLP with the Cargo Protein-SP fusion protein
incorporated on the interior. Utilizing this approach P22 VLPs containing the conserved
nucleoprotein (NP) from influenza on the interior, in a biomimetic fashion, were shown to
elicit a broadly protective CD8+ T cell response to influenza that provided multi-strain
protection against 100 times lethal doses of influenza. These results provide strong evidence
for utilizing our biomimetic approach, which is amendable to the quick production of
vaccines to rapidly emerging pathogens. Investigations into a modular approach for
attaching antigenic proteins to exterior of the P22 VLP, allowing display of antigens on the
exterior or P22, is described. For proof of concept, green fluorescent protein (GFP) was
utilized as a model protein for examining attachment of proteins to the exterior of the P22
VLP via sortase-mediated ligation. Results show that GFP can be effectively attached to the
surface of P22, paving the way for attachment of other proteins,
including antigenic proteins from pathogens. The ability to display
antigens on the outside has the potential to activate alternate
immunologic pathways, such as production of neutralizing
antibodies that prevent pathogen infections. Tailoring the display of
antigens has the potential to allow control over directing the
specific immune pathway activated and responses generated.

Screening Sortase-Mediated Ligation of GFP to P22
-Polygylcine-GFP was used as a model
protein/antigen to screen conditions for
sortase-mediated ligation to P22 exterior.
-Ratios of reactants GFP and P22 (total
conc. 60 μM) and sortase examined to
find best conditions.

NP-P22

200 nm

Influenza

-Biomimetic display of nucleoprotein (NP, green) within P22 is expected to generate
a broadly protective CD8+ T cell response.
-Constructs containing full length NP were constructed by in vivo expression in E.
coli (TEM image).

-Effective crosslinking observed,
especially at higher concentrations of
sortase.

Ratio of Sortase to Reactants

-Antigen incorporated by in vivo
co-expression of antigenscaffolding protein fusion
protein (SP, truncated) with P22
Coat Protein (CP).

= Full length
scaffolding protein
= Truncated
scaffolding protein
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-In vivo expression produces high
yields (up to 200 mg/Liter) of
homogenous P22 VLPs.

C

Coat protein

Antigen protein fusion to scaffold

-Rapid generation of new immunogenic nanoparticles
using recombinant DNA technology to fight newly
emerging pathogens.

-Conserved components of
external proteins could be
utilized to construct broadly
protective vaccines.

NP-specific Ab
binds and lyses
influenza- infected
cell

Host epithelial cell

Sortase

1:1 GFP to P22 CP

10:1 GFP to P22 CP

-Ultracentrifugation of P22/GFP reactions
through a cesium chloride (CsCl) gradient
(0.2 mg/mL-0.4 mg/mL) resulted in green
colored bands where white P22 VLP bands
are normally observed.
Purified P22-GFP

-Fractionation and analysis of CsCl bands
confirmed that GFP was covalently crosslinked to P22 via sortase.
-Results validate sortase-mediated approach
for attachment of proteins to the exterior of
the P22 VLP platform.

-NP-P22 generates multi-serotype protection in mice treated with high doses (50 times lethal
doses) of H1N1 (PR8) and H3N2 (X31).
-Weight data shows recovery by influenza infected mice immunized with NP-P22.
-TIB210 CD8+ T cell depletion combined with MHCI tetramer staining of CD8+ T cells
indicate response is CD8+ dependent and NP specific.

Developing Approach for External Display of Antigens on P22

Future Directions
- Further evaluate P22-GFP VLP materials
constructed.
-Use sortase method to incorporate
influenza antigen on exterior to provide
broadly protective neutralizing antibody
response.
-Explore how antigen display on interior vs.
exterior modulates the response generated to
antigens.

HA-specific
neutralizing
antibodies
binds free virus and
inhibits infection
of the cell

NP-specific CD8 cytolytic cell
binds and lyses the influenzainfected cell

GFP

-Based on reaction screens, reaction size was
scaled up (~4 mL) and performed for optimal
time (4 hours) at 1:10 P22 to GFP ratios at
higher protein concentrations (120 μM).

Protection Generated Against Influenza by NP-P22 is NP-Specific

Influenza virus

-Nucleoprotein (NP) is
conserved across serotypes of
influenza and generates CD8+
T cell response that aids in
clearance of infected cells.

P22 CP
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-SDS-PAGE, TEM, and size exclusion chromatography verified NP incorporation
and homogeneous particle formation with high internal packaging of 145 copies of
NP per capsid.

Targeting Influenza Immune Responses
-Current vaccine strategies
against influenza largely
target non-conserved
Hemagglutinin (HA) to
generate neutralizing antibody
response.

P22 CP-GFP
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P22 VLP as Platform for Internal Display of Antigens
= Coat protein
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Scaling Up Sortase-Mediated Ligation of GFP to P22

Recombinant Bacteriophage P22 VLP Cryo-EM Model
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Expected Mol. Weights
20 kDa Sortase
28 kDa GFP
47 kDa P22 CP
75 kDa P22 CP-GFP
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